Findings

What do systematic reviews say?

17 questions · 17 findings · 10 reviews · Breast Cancer

Sort:Best matchNewest Highest certainty Download CSV

No studies found 2 · 11.8%GRADE not reported 1 · 5.9%Very low 2 · 11.8%Low 8 · 47.1%Moderate 4 · 23.5%High 0 · 0%

Platinum‐containing chemotherapy vs chemotherapy without platinum

Quality of life · early triple‐negative breast cancer

The review found no eligible studies for this question.

1 finding from 1 review

Platinum‐based chemotherapy for early triple‐negative breast cancer 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Taxane‐containing chemotherapy vs any chemotherapy without taxane

Quality of life · women with early breast cancer

1 finding from 1 review

Taxanes for adjuvant treatment of early breast cancer 2019 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 7 participants
Low

Summary of findings table ‐ Systemic therapy vs control

Health‐related quality of life (HRQoL) · women with early breast cancer

1 finding from 1 review

Systemic therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast… 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1 participants
Low

Summary of findings table ‐ Postmastectomy radiotherapy (PMRT) vs no PMRT

QoL · women with breast cancer and one to three positive lymph nodes

1 finding from 1 review

Post‐mastectomy radiotherapy for women with early breast cancer and one to three positive lymph nodes 2023 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Taxane followed by anthracyclines vs anthracyclines followed by taxane

Quality of life ( · adjuvant therapy for early breast cancer

1 finding from 1 review

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 20 participants
Moderate

Taxane followed by anthracyclines vs anthracyclines followed by taxane

Quality of life · neoadjuvant therapy for early breast cancer

The review found no eligible studies for this question.

1 finding from 1 review

Sequencing of anthracyclines and taxanes in neoadjuvant and adjuvant therapy for early breast cancer 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Systemic therapy vs control

Health‐related quality of life (HRQoL) · health problem or population

1 finding from 1 review

Systemic therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast… 2022 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 208 participants
Very low

CBT vs control

QoL · Women with non‐metastatic breast cancer

1 finding from 1 review

Psychological interventions for women with non‐metastatic breast cancer 2023 · Cochrane Headline outcomes only
no estimate extracted
20 studies · 1747 participants
Low

Summary of findings table ‐ Systemic therapy vs control

Effect on breast cancer‐specific quality of life (BCS‐QoL) · health problem or population

1 finding from 1 review

Systemic therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast… 2022 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 147 participants
Very low

Summary of findings table ‐ Systemic therapy vs control

Effect on breast cancer‐specific quality of life (BCS‐QoL) · women with early breast cancer

1 finding from 1 review

Systemic therapies for preventing or treating aromatase inhibitor‐induced musculoskeletal symptoms in early breast… 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 44 participants
Low

Exercise vs control

Health‐related quality of life · women receiving adjuvant therapy (chemo‐ or radiotherapy or both) for breast cancer

1 finding from 1 review

Exercise for women receiving adjuvant therapy for breast cancer 2016 · Cochrane Headline outcomes only
no estimate extracted
1 study · 68 participants
Low

Exercise vs control

Cancer‐specific quality of life · women receiving adjuvant therapy (chemo‐ or radiotherapy or both) for breast cancer

1 finding from 1 review

Exercise for women receiving adjuvant therapy for breast cancer 2016 · Cochrane Headline outcomes only
no estimate extracted
12 studies · 1012 participants
Moderate

Capecitabine‐containing regimens vs chemotherapy regimens without capecitabine

Quality of life · people with metastatic breast cancer

1 finding from 1 review

Capecitabine for hormone receptor‐positive versus hormone receptor‐negative breast cancer 2021 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 5 participants
Low

Exercise vs control

Cancer site‐specific quality of life · women receiving adjuvant therapy (chemo‐ or radiotherapy or both) for breast cancer

1 finding from 1 review

Exercise for women receiving adjuvant therapy for breast cancer 2016 · Cochrane Headline outcomes only
no estimate extracted
4 studies · 262 participants
Low

Intervention not reported

Quality of Life FACT‐B Functional Assessment of Cancer Therapy ‐ Breast Cancer Specific Scale from: 0‐144 · breast cancer survivors

1 finding from 1 review

Home‐based multidimensional survivorship programmes for breast cancer survivors 2017 · Cochrane Headline outcomes only
no estimate extracted
7 studies · 764 participants
Moderate

Yoga vs no therapy

Health‐related quality of life (short‐term) Self‐assessed questionnaires · women with diagnosed breast cancer

1 finding from 1 review

Yoga for improving health‐related quality of life, mental health and cancer‐related symptoms in women diagnosed with… 2017 · Cochrane Headline outcomes only
no estimate extracted
10 studies · 675 participants
Moderate

Yoga vs no therapy

Health‐related quality of life (medium‐term) Self‐assessed questionnaires · women with diagnosed breast cancer

1 finding from 1 review

Yoga for improving health‐related quality of life, mental health and cancer‐related symptoms in women diagnosed with… 2017 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 146 participants
Low